Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531).

× No keyword cloud information.

6 in total

Review 1. Romiplostim: a review of its use in immune thrombocytopenia.

Authors: Gillian M Keating
Journal: Drugs Date: 2012-02-12 Impact factor: 9.546

2. The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia.

Authors: Nichola Cooper; Ilaria Terrinoni; Adrian Newland
Journal: Ther Adv Hematol Date: 2012-10

3. Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors: Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal: Blood Adv Date: 2019-11-26

4. Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim.

Authors: Marc Michel; Peter A W te Boekhorst; Ann Janssens; Ingrid Pabinger-Fasching; Miguel A Sanz; Kun Nie; Georg Kreuzbauer
Journal: Hematology Date: 2011-09 Impact factor: 2.269

5. A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists.

Authors: Meaghan Khan; Joseph Mikhael
Journal: J Blood Med Date: 2010-03-23

6. Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland.

Authors: Dawn Lee; Patrick Thornton; Alexander Hirst; Lucie Kutikova; Robert Deuson; Nic Brereton
Journal: Appl Health Econ Health Policy Date: 2013-10 Impact factor: 2.561

6 in total